BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160704
DTEND;VALUE=DATE:20160901
DTSTAMP:20260901T170523
CREATED:20160704T183407Z
LAST-MODIFIED:20160705T124600Z
UID:16304-1467590400-1472687999@ces.b2sg.org
SUMMARY:Postdoctoral Research Associate in pancreatic cancer pathogenesis (Chapel Hill\, NC\, USA)
DESCRIPTION:Lineberger Comprehensive Cancer Center Research Laboratory aims to understand the pathogenesis and pharmacogenomics of pancreatic cancer in order to accelerate its treatment. Using a combination of molecular and genomic data\, and human in mouse models\, we have identified four core subtypes in pancreatic cancer with important biologic and clinical implications. We are seeking a postdoctoral associate in cancer genomics and personalized medicine who will be responsible for computational method development\, data analysis\, and experimental design. The qualified candidate will integrate information from a combination of sources\, including high throughput screens\, proteomic\, and next-gen sequencing data in order to generate and validate hypotheses of therapeutic relevance to pancreatic cancer. The ideal candidate will have excellent qualifications in a quantitative/computational field with a strong interest in learning cancer biology and/or wet bench techniques. Candidates from a largely wet bench background with a Ph.D. may be considered if the quantitative/computational background is excellent. \nTo be successful\, the candidate must have experience in and interested in developing several of the following skill-sets: thorough knowledge of cancer biology\, epigenetics\, proteomics\, and transcriptomics; familiarity with next-generation sequencing data analysis tools; experience working in Linux environments\, including batch job management on shared computing resources; familiarity with a variety of supervised and unsupervised classification techniques; proficiency in one or more statistical or scripting languages\, preferably R or MATLAB; knowledge of survival-based statistical analysis\, e.g. Cox regression and Kaplan-Meier analysis; working knowledge of best-practices for machine learning to avoid over fitting; familiarity with common experimental techniques in molecular biology; ability to communicate scientific material and collaborate well with computational and non-computational partners; excellent oral and written communication skills and the ability to perform both self-directed and guided research; outstanding personal initiative and the ability to work effectively as part of a team; willingness to assist in the mentorship and training of pre-doctoral researchersPh.D. in a quantitative/computational field or a Ph.D. with an equivalent certificate in a quantitative/computational field is required; have experience in handling large datasets and have applied/developed computational algorithms in the context of molecular biology; have a thorough understanding of common statistical tests and distributions; be able to collaborate with experimental team members for validation of computational results; be comfortable maintaining datasets\, as well as displaying and interpreting processed data for publication; work alongside domain experts in the optimization and development of experimental measurement platforms and protocols.
URL:https://ces.b2sg.org/event/postdoctoral-research-associate-in-pancreatic-cancer-pathogenesis/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160705
DTEND;VALUE=DATE:20161101
DTSTAMP:20260901T170523
CREATED:20160705T124949Z
LAST-MODIFIED:20160706T133740Z
UID:16333-1467676800-1477958399@ces.b2sg.org
SUMMARY:Postdoc in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A postdoctoral position is immediately available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks (ULB – Université Libre de Bruxelles/Free University of Brussels\, Belgium). \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS (http://epics.ulb.be/) and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, encompassing fundamental\, translational and clinical research and providing an excellent scientific environment to conduct high profile research.\nWe are looking for a highly motivated candidate with extensive experience in molecular and cell biology. Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related disciplines (or have recently submitted their thesis with their defence scheduled) and have published (or about to publish) in a peer reviewed journal. Experience in epigenetics/epigenomics would be an asset. \nThe position is funded for 3 years. Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date. \nInformal enquiries\, a CV\, a motivation letter and names of two referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab\nLab NGS platform: http://epics.ulb.be/ \nSelected publications:\n– Delatte et al. Science 2016\n– Delatte et al. Science Rep. 2015\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature. 2010\n– Epsztejn-Litman Nat Struct Mol Biol. 2008\n– Villa et al. Cancer Cell. 2007\n– Brenner & Fuks Dev Cell. 2007\n– Viré et al. Nature 2006\n– Brenner et al. EMBO J. 2005
URL:https://ces.b2sg.org/event/postdoc-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160706
DTEND;VALUE=DATE:20161101
DTSTAMP:20260901T170523
CREATED:20160706T131829Z
LAST-MODIFIED:20160706T133508Z
UID:16337-1467763200-1477958399@ces.b2sg.org
SUMMARY:PhD in Epigenetics/Cancer (Brussels\, Belgium)
DESCRIPTION:A PhD position is available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks at the Université libre de Bruxelles (ULB)\, Brussels\, Belgium. \nYou will be expected to conduct cancer research in epigenetics and epigenomics. Specifically\, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B\, et al.\, Science. 2016; 351:282-5. Genetic\, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq\, ChIP-Seq\, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS\, and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks\, providing an excellent scientific environment to conduct high profile research encompassing fundamental\, translational and clinical research. \nCandidates with a good first degree (BSc or MSc) in Biology\, Genetics\, Biochemistry or a related life science subject are all invited to apply. Preferred qualifications include excellent grades\, research talent (as proven by the master thesis) and personal ambition. Candidates are expected to have good academic writing and presentation skills. Screening of applications begins immediately and continues until an outstanding candidate is selected. \nThe position is funded for 3 years\, in the first instance. Screening of applications begins immediately and continues until an outstanding candidate is selected. The starting date is September 30\, 2016 at the latest. \nInformal enquiries\, a CV (including grades and class ranking)\, a motivation letter and names of three referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be) \nLab website: http://www.ulb.ac.be/medecine/fukslab \nLab NGS platform EPICS: http://epics.ulb.be/ \nUniversity website: https://www.ulb.ac.be/ulb/presentation/uk.html \nSelected publications:\n– Delatte et al. Science 2016\n– Boumahdi et al. Nature 2014\n– Deplus et al. Cell Rep. 2014\n– Delatte et al. EMBO J. 2014\n– Deplus et al. EMBO J. 2013\n– Volkmar et al. EMBO J. 2012\n– Dedeurwaerder et al. EMBO Mol Med. 2011\n– Fuks F. Nature 2010\n– Villa et al. Cancer Cell 2007\n– Viré et al. Nature 2006
URL:https://ces.b2sg.org/event/phd-in-epigeneticscancer-brussels-belgium/
LOCATION:ULB\,  Université libre de Bruxelles Campus Erasme\, Anderlecht\, 1070\, Belgium
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2016/07/ULB-Epigenetics-lab.jpg
ORGANIZER;CN="ULB-Lab%20Cancer%20Epigenetics":MAILTO:epics@ulb.ac.be
END:VEVENT
END:VCALENDAR